COVID ‐19 associated severe mucocutaneous blistering eruptions: A case series
Pediatric Dermatology · 2023
DOI: 10.1111/pde.15407 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pediatric Dermatology, 2023. Verfasst von Allison E Miller und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA. Hauptthemen laut MEDLINE: COVID-19, Stevens-Johnson Syndrome, Erythema Multiforme, Exanthema. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Mucocutaneous eruptions are associated with numerous infectious processes and can present as erythema multiforme (EM), reactive infectious mucocutaneous eruption (RIME), Stevens Johnson syndrome (SJS), or toxic epidermal necrolysis (TEN). Limited reports have detailed the association of these eruptions with SARS‐CoV‐2 infection. We present a series of eight cases of severe mucocutaneous blistering eruptions associated with SARS‐CoV‐2 infection. A retrospective case series was performed at six tertiary medical centers from March 1, 2020 to August 1, 2022. Inclusion criteria were met with a clinical diagnosis of EM, RIME, SJS, or TEN and a positive SARS‐CoV‐2 test (rapid antigen or polymerase chain reaction) less than 4 weeks prior to onset of dermatologic manifestation. Data was collected at time of each patient encounter. Eight patients met criteria with six pediatric patients (18 years of age) having a median age of 36 years. Patients were found to have a clinical diagnosis of RIME in 85.7% of cases. Oral mucosal involvement was the most common clinical finding (100%), followed by ocular (50.0%), urogenital (50.0%), and skin (37.5%) involvement. Evaluation did not reveal any additional infectious triggers in four patients. Evidence of possible concurrent or previous infectious triggers were identified in four patients. This case series highlights the development of severe mucocutaneous eruptions in association with COVID‐19 infection, as well as the potential contributing role of concurrent or prior infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
- San Matteo Research Hospital, Pavia, Italy.
- ASST Fatebenefratelli Sacco, Pediatric Unit, Milan, Italy.
- Department of Pediatrics, Department of Medicine, University of Calgary, Calgary, Canada.
- Division of Dermatology, Department of Pediatrics, Hospital for Sick Children, University of Toronto, Toronto, Canada.
- Division of Dermatology, Children's National Hospital, Washington, DC, USA.
ORCID-Profile: Allison E Miller, Michele Ramien, Irene Lara-Corrales, Sheilagh Maguiness
Zitieren
APA
Miller, A. E., Zhang, D., Shields, B. E., Borghesi, A., Benincaso, A. R., Bernardo, L., Ramien, M., Lara-Corrales, I., Kirkorian, A. Y., Maguiness, S., & Drolet, B. (2023). COVID ‐19 associated severe mucocutaneous blistering eruptions: A case series. Pediatric Dermatology. https://doi.org/10.1111/pde.15407
Vancouver
Miller AE, Zhang D, Shields BE, Borghesi A, Benincaso AR, Bernardo L, et al. COVID ‐19 associated severe mucocutaneous blistering eruptions: A case series. Pediatric Dermatology. 2023. doi:10.1111/pde.15407
BibTeX
@article{Miller2023,
author = {Miller, Allison E and Zhang, Donglin and Shields, Bridget E and Borghesi, Alessandro and Benincaso, Anna R and Bernardo, Luca and Ramien, Michele and Lara-Corrales, Irene and Kirkorian, A Yasmine and Maguiness, Sheilagh and Drolet, Beth},
title = {COVID ‐19 associated severe mucocutaneous blistering eruptions: A case series},
journal = {Pediatric Dermatology},
year = {2023},
doi = {10.1111/pde.15407}
}
EUVIMED